P. The, NK-depleted PBMCs were cultured at a 1 10 6 cells/ml density of in RPMI-1640 supplemented with 2 mM L-glutamine, penicillin (50 UI/ml), streptomycin (50 µg/ml), 50 µM 5-mercapthoéthanol and 10% heat-inactivated fetal bovine serum

S. P. Adekar, R. M. Jones, M. D. Elias, F. H. Al-saleem, M. J. Root et al., A Human Monoclonal Antibody that Binds Serotype A Botulinum Neurotoxin, Hybridoma, vol.27, issue.1, pp.11-18, 2008.
DOI : 10.1089/hyb.2007.0536

A. Albini, R. Benelli, D. Giunciuglio, T. Cai, G. Mariani et al., Identification of a Novel Domain of HIV Tat Involved in Monocyte Chemotaxis, Journal of Biological Chemistry, vol.273, issue.26, pp.15895-900, 1998.
DOI : 10.1074/jbc.273.26.15895

A. Albini, R. Benelli, M. Presta, M. Rusnati, M. Ziche et al., HIV-tat protein is a heparin-binding angiogenic growth factor, Oncogene, vol.12, pp.289-97, 1996.

A. Albini, R. Soldi, D. Giunciuglio, E. Giraudo, R. Benelli et al., The angiogenesis induced by HIV???1 Tat protein is mediated by the Flk???1/KDR receptor on vascular endothelial cells, Nature Medicine, vol.96, issue.12, pp.1371-1376, 1996.
DOI : 10.1056/NEJM199505043321801

C. A. Borrebaeck, Human mAbs produced by primary in-vitro immunization, Immunology Today, vol.9, issue.11, pp.355-364, 1988.
DOI : 10.1016/0167-5699(88)91337-0

C. A. Borrebaeck, L. Danielsson, and &. S. Möller, Human monoclonal antibodies produced from L-leucine methyl ester-treated and in vitro immunized peripheral blood lymphocytes, Biochemical and Biophysical Research Communications, vol.148, issue.3, pp.941-947, 1987.
DOI : 10.1016/S0006-291X(87)80223-1

C. A. Borrebaeck, L. Danielsson, and &. S. Möller, Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes., Proceedings of the National Academy of Sciences, vol.85, issue.11, pp.3995-4004, 1988.
DOI : 10.1073/pnas.85.11.3995

P. Brams, I. Royston, and &. P. Boerner, In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements, Hum Antibodies Hybridomas, vol.4, pp.47-56, 1993.

P. Brams, I. Royston, and &. P. Boerner, In vitro priming of human lymphocytes. II. Induction of antigen-specific IgG responses by repeated antigen stimulation, Hum Antibodies Hybridomas, vol.4, pp.57-65, 1993.

L. Buonaguro, G. Barillari, H. K. Chang, C. A. Bohan, V. Kao et al., Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines, J Virol, vol.66, pp.7159-67, 1992.

L. T. Chin, J. Hinkula, M. Levi, M. Ohlin, B. Wahren et al., Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors, Immunology, vol.81, pp.428-462, 1994.

L. Danielsson, S. A. Möller, and &. C. Borrebaeck, Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens, Immunology, vol.61, pp.51-56, 1987.

S. K. Dessain, S. P. Adekar, J. B. Stevens, K. A. Carpenter, M. L. Skorski et al., High efficiency creation of human monoclonal antibody-producing hybridomas, Journal of Immunological Methods, vol.291, issue.1-2, pp.109-131, 2004.
DOI : 10.1016/j.jim.2004.05.005

R. Alvarez, G. Tambussi, C. Tassan-din, G. Palamara, A. Latini et al., The preventive phase I trial with the HIV-1 Tat-based vaccine, Vaccine, vol.28, pp.371-379, 2009.

B. Ensoli, R. Gendelman, P. Markham, V. Fiorelli, S. Colombini et al., Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma, Nature, vol.371, issue.6499, pp.674-80, 1994.
DOI : 10.1038/371674a0

E. Fanales-belasio, S. Moretti, F. Nappi, G. Barillari, F. Micheletti et al., Native HIV-1 Tat Protein Targets Monocyte-Derived Dendritic Cells and Enhances Their Maturation, Function, and Antigen-Specific T Cell Responses, The Journal of Immunology, vol.168, issue.1, pp.197-206, 2002.
DOI : 10.4049/jimmunol.168.1.197

F. Ferrantelli, M. T. Maggiorella, I. Schiavoni, L. Sernicola, E. Olivieri et al., A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study, Vaccine, vol.29, issue.16, pp.2918-2950, 2011.
DOI : 10.1016/j.vaccine.2011.02.006

A. Gadzinski, D. Matz, E. Favre, and &. M. Léonetti, Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens, Vaccine, vol.30, issue.18, pp.2859-68, 2012.
DOI : 10.1016/j.vaccine.2012.02.042

A. Ichikawa, Y. Katakura, K. Teruya, S. Hashizume, and &. S. Shirahata, In vitro immunization of human peripheral blood lymphocytes: establishment of B cell lines secreting IgM specific for cholera toxin B subunit from lymphocytes stimulated with IL-2 and IL-4, Cytotechnology, vol.31, issue.1/2, pp.133-141, 1999.
DOI : 10.1023/A:1008063903946

E. Izmailova, F. M. Bertley, Q. Huang, N. Makori, C. J. Miller et al., HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages, Nature Medicine, vol.9, issue.2, pp.191-198, 2003.
DOI : 10.1038/nm822

A. Jakobovits, G. J. Vergara, J. L. Kennedy, J. F. Hales, R. P. Mcguinness et al., Analysis of homozygous mutant chimeric mice: deletion of the immunoglobulin heavy-chain joining region blocks B-cell development and antibody production., Proceedings of the National Academy of Sciences, vol.90, issue.6, pp.2551-2556, 1993.
DOI : 10.1073/pnas.90.6.2551

K. G. James and . Bell, Human monoclonal antibody production, Journal of Immunological Methods, vol.100, issue.1-2, pp.5-40, 1987.
DOI : 10.1016/0022-1759(87)90170-0

J. Kittiworakarn, A. Lecoq, G. Moine, R. Thai, E. Lajeunesse et al., HIV-1 Tat Raises an Adjuvant-free Humoral Immune Response Controlled by Its Core Region and Its Ability to Form Cysteine-mediated Oligomers, Journal of Biological Chemistry, vol.281, issue.6, pp.3105-3120, 2006.
DOI : 10.1074/jbc.M509899200

D. Kozbor, D. Dexter, and &. J. Roder, A Comparative Analysis of the Phenotypic Characteristics of Available Fusion Partners for the Construction of Human Hybridomas, Hybridoma, vol.2, issue.1, pp.7-16, 1983.
DOI : 10.1089/hyb.1983.2.7

D. Kozbor, J. C. Roder, T. H. Chang, Z. Steplewski, and &. H. Koprowski, Human Anti-Tetanus Toxoid Monoclonal Antibody Secreted by EBV-Transformed Human B Cells Fused with Murine Myeloma, Hybridoma, vol.1, issue.3, pp.323-331, 1982.
DOI : 10.1089/hyb.1.1982.1.323

J. B. Lagacé and . Brodeur, Parameters affecting in vitro immunization of human lymphocytes, Journal of Immunological Methods, vol.85, issue.1, pp.127-163, 1985.
DOI : 10.1016/0022-1759(85)90281-9

M. Léonetti, A. Gadzinski, and &. G. Moine, Cell Surface Heparan Sulfate Proteoglycans Influence MHC Class II-Restricted Antigen Presentation, The Journal of Immunology, vol.185, issue.7, pp.3847-56, 2010.
DOI : 10.4049/jimmunol.0902724

M. Léonetti, R. Thai, J. Cotton, S. Leroy, P. Drevet et al., Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting, J Immunol, vol.160, pp.3820-3827, 1998.

J. D. Marks, H. R. Hoogenboom, T. P. Bonnert, J. Mccafferty, A. D. Griffiths et al., By-passing immunization, Journal of Molecular Biology, vol.222, issue.3, pp.581-97, 1991.
DOI : 10.1016/0022-2836(91)90498-U

J. Mccafferty, A. D. Griffiths, G. Winter, and &. J. , Phage antibodies: filamentous phage displaying antibody variable domains, Nature, vol.348, issue.6301, pp.552-556, 1990.
DOI : 10.1038/348552a0

L. Olsson, H. Kronstrøm, A. Cambon-de-mouzon, C. Honsik, T. Brodin et al., Antibody producing human-human hybridomas. I. Technical aspects, Journal of Immunological Methods, vol.61, issue.1, pp.17-32, 1983.
DOI : 10.1016/0022-1759(83)90004-2

S. Y. Shim, Y. Katakura, A. Ichikawa, K. Teruya, T. Matsuda et al., Epitope analysis of human monoclonal antibody specific for rice allergenic protein generated by in vitro immunization, Cytotechnology, vol.36, issue.1/3, pp.109-124, 2001.
DOI : 10.1023/A:1014012214095

M. Steinitz, Three decades of human monoclonal antibodies: past, present and future developments, Hum Antibodies, vol.18, pp.1-10, 2009.

D. L. Thiele, M. Kurosaka, and &. P. Lipsky, Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester, J Immunol, vol.131, pp.2282-90, 1983.

E. Traggiai, S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu et al., An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus, Nature Medicine, vol.162, issue.8, pp.871-876, 2004.
DOI : 10.1128/JVI.77.19.10394-10403.2003

S. T. Uthoff and . Böldicke, In vitro immunization of mouse spleen cells for the production of monoclonal IgG1 antibodies using an antigen-specific T helper cell clone (D.10.G4.1), Journal of Immunological Methods, vol.166, issue.2, pp.165-75, 1993.
DOI : 10.1016/0022-1759(93)90357-D

A. Tissent, N. H. , F. Sadiq, N. Amrani, and N. Benchemsi, Production of anti-B human monoclonal reagent for the detection of the blood groups ABO, 2007.

R. Abès, C. A. Dutertre, and J. L. Teillaud, [Antibodies: better knowledge for a better use, Med Sci, pp.25-1011, 2009.

G. P. Adams, R. Schier, A. M. Mccall, H. H. Simmons, E. M. Horak et al., High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules, Cancer Res, pp.61-4750, 2001.

S. P. Adekar, R. M. Jones, M. D. Elias, F. H. Al-saleem, M. J. Root et al., A Human Monoclonal Antibody that Binds Serotype A Botulinum Neurotoxin, Hybridoma, vol.27, issue.1, pp.27-38, 2008.
DOI : 10.1089/hyb.2007.0536

S. P. Adekar, T. Takahashi, R. M. Jones, F. H. Al-saleem, D. M. Ancharski et al., Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain, PLoS ONE, vol.304, issue.8, p.3023, 2008.
DOI : 10.1371/journal.pone.0003023.t002

A. Albini, R. Benelli, M. Presta, M. Rusnati, M. Ziche et al., HIV-tat protein is a heparin-binding angiogenic growth factor, pp.12-289, 1996.

P. Amersdorfer, C. Wong, S. Chen, T. Smith, R. Deshpande et al., Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries, Infect Immun, pp.65-3743, 1997.

R. M. Anthony, F. Wermeling, M. C. Karlsson, and J. V. Ravetch, Identification of a receptor required for the anti-inflammatory activity of IVIG, Proceedings of the National Academy of Sciences, vol.105, issue.50, pp.19571-19579, 2008.
DOI : 10.1073/pnas.0810163105

M. Arbabi-ghahroudi, J. Tanha, and R. Mackenzie, Prokaryotic expression of antibodies, Cancer and Metastasis Reviews, vol.341, issue.4, pp.24-501, 2005.
DOI : 10.1007/s10555-005-6193-1

J. P. Arbuthnott, D. C. Coleman, and J. S. De-azavedo, Staphylococcal toxins in human disease, Journal of Applied Bacteriology, vol.ii, pp.101-107, 1990.
DOI : 10.1111/j.1365-2672.1990.tb01802.x

J. W. Arndt, M. J. Jacobson, E. E. Abola, C. M. Forsyth, W. H. Tepp et al., A Structural Perspective of the Sequence Variability Within Botulinum Neurotoxin Subtypes A1-A4, Journal of Molecular Biology, vol.362, issue.4, pp.362-733, 2006.
DOI : 10.1016/j.jmb.2006.07.040

J. N. Arnold, M. R. Wormald, R. B. Sim, P. M. Rudd, and R. A. Dwek, The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins, Annual Review of Immunology, vol.25, issue.1, pp.25-46, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141702

S. S. Arnon, R. Schechter, T. V. Inglesby, D. A. Henderson, J. G. Bartlett et al., Botulinum Toxin as a Biological Weapon, JAMA, vol.285, issue.8, pp.285-1059, 2001.
DOI : 10.1001/jama.285.8.1059

G. Aversa, J. Punnonen, J. M. Carballido, B. G. Cocks, and J. E. De-vries, CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells, Seminars in Immunology, vol.6, issue.5, pp.295-301, 1994.
DOI : 10.1006/smim.1994.1038

D. T. Avery, V. L. Bryant, C. S. Ma, R. De-waal-malefyt, and S. G. Tangye, IL-21-Induced Isotype Switching to IgG and IgA by Human Naive B Cells Is Differentially Regulated by IL-4, The Journal of Immunology, vol.181, issue.3, pp.181-1767, 2008.
DOI : 10.4049/jimmunol.181.3.1767

N. Balaban and A. Rasooly, Staphylococcal enterotoxins, International Journal of Food Microbiology, vol.61, issue.1, pp.61-62, 2000.
DOI : 10.1016/S0168-1605(00)00377-9

C. F. Barbas, A. S. Kang, R. A. Lerner, and S. J. Benkovic, Assembly of combinatorial antibody libraries on phage surfaces: the gene III site., Proceedings of the National Academy of Sciences, vol.88, issue.18, pp.88-7978, 1991.
DOI : 10.1073/pnas.88.18.7978

A. Beck, E. Wagner-rousset, T. Wurch, and N. Corvaia, Therapeutic antibodies and related products: choosing the right structure for success], Med Sci, pp.25-1024, 2009.

A. Beck, T. Wurch, C. Bailly, and N. Corvaia, Strategies and challenges for the next generation of therapeutic antibodies, Nature Reviews Immunology, vol.368, issue.5, pp.345-52, 2010.
DOI : 10.1038/nri2747

G. Behar, P. Chames, I. Teulon, A. Cornillon, F. Alshoukr et al., Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen, FEBS Journal, vol.31, issue.14, pp.276-3881, 2009.
DOI : 10.1111/j.1742-4658.2009.07101.x
URL : https://hal.archives-ouvertes.fr/hal-00414287

J. A. Bell, T. H. Pennington, and D. T. Petrie, Western blot analysis of staphylococcal antibodies present in human sera during health and disease, Journal of Medical Microbiology, vol.23, issue.2, pp.95-104, 1987.
DOI : 10.1099/00222615-23-2-95

N. K. Bender, C. E. Heilig, B. Dröll, J. Wohlgemuth, F. P. Armbruster et al., Immunogenicity, efficacy and adverse events of adalimumab in RA patients, Rheumatology International, vol.343, issue.3, pp.27-269, 2007.
DOI : 10.1007/s00296-006-0183-7

C. L. Benedict, S. Gilfillan, T. H. Thai, and J. F. Kearney, Terminal deoxynucleotidyl transferase and repertoire development, Immunological Reviews, vol.175, issue.1, pp.175-150, 2000.
DOI : 10.1111/j.1600-065X.2000.imr017518.x

E. Bengtén, M. Wilson, N. Miller, L. W. Clem, L. Pilström et al., Immunoglobulin Isotypes: Structure, Function, and Genetics, Curr Top Microbiol Immunol, pp.248-189, 2000.
DOI : 10.1007/978-3-642-59674-2_9

M. S. Bergdoll, B. A. Crass, R. F. Reiser, R. N. Robbins, and J. P. Davis, A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATES, The Lancet, vol.317, issue.8228, pp.1017-1038, 1981.
DOI : 10.1016/S0140-6736(81)92186-3

N. L. Bernasconi, E. Traggiai, and A. Lanzavecchia, Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells, Science, vol.298, issue.5601, pp.298-2199, 2002.
DOI : 10.1126/science.1076071

G. A. Bohach, D. J. Fast, R. D. Nelson, and P. M. Schlievert, Staphylococcal and Streptococcal Pyrogenic Toxins Involved in Toxic Shock Syndrome and Related Illnesses, Critical Reviews in Microbiology, vol.321, issue.4, pp.17-251, 1990.
DOI : 10.1021/bi00829a012

J. W. Boles, M. L. Pitt, R. D. Leclaire, P. H. Gibbs, E. Torres et al., Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity, Clinical Immunology, vol.108, issue.1, pp.51-60, 2003.
DOI : 10.1016/S1521-6616(03)00066-4

C. A. Borrebaeck, In Vitro Immunization for the Production of Antigen-Specific Lymphocyte Hybridomas, Scandinavian Journal of Immunology, vol.25, issue.1, pp.9-12, 1983.
DOI : 10.1038/276269a0

C. A. Borrebaeck, Human mAbs produced by primary in-vitro immunization, Immunology Today, vol.9, issue.11, pp.355-364, 1988.
DOI : 10.1016/0167-5699(88)91337-0

C. A. Borrebaeck, L. Danielsson, and S. A. Möller, Human monoclonal antibodies produced from L-leucine methyl ester-treated and in vitro immunized peripheral blood lymphocytes, Biochemical and Biophysical Research Communications, vol.148, issue.3, pp.148-941, 1987.
DOI : 10.1016/S0006-291X(87)80223-1

C. A. Borrebaeck, L. Danielsson, and S. A. Möller, Human monoclonal antibodies produced by primary in vitro immunization of peripheral blood lymphocytes., Proceedings of the National Academy of Sciences, vol.85, issue.11, pp.85-3995, 1988.
DOI : 10.1073/pnas.85.11.3995

P. Brams, I. Royston, and P. Boerner, In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements, Hum Antibodies Hybridomas, issue.4, pp.47-56, 1993.

P. Brams, I. Royston, and P. Boerner, In vitro priming of human lymphocytes. II. Induction of antigen-specific IgG responses by repeated antigen stimulation, Hum Antibodies Hybridomas, issue.4, pp.57-65, 1993.

A. Buchacher, R. Predl, K. Strutzenberger, W. Steinfellner, A. Trkola et al., Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization, AIDS Research and Human Retroviruses, vol.10, issue.4, pp.359-69, 1994.
DOI : 10.1089/aid.1994.10.359

G. R. Campbell and E. P. Loret, What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?, Retrovirology, vol.6, issue.1, p.50, 2009.
DOI : 10.1186/1742-4690-6-50

D. J. Capon, S. M. Chamow, J. Mordenti, S. A. Marsters, T. Gregory et al., Designing CD4 immunoadhesins for AIDS therapy, Nature, vol.337, issue.6207, pp.337-525, 1989.
DOI : 10.1038/337525a0

A. T. Carter, C. J. Paul, D. R. Mason, S. M. Twine, M. J. Alston et al., Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum, BMC Genomics, vol.10, issue.1, p.115, 2009.
DOI : 10.1186/1471-2164-10-115

P. J. Carter, Potent antibody therapeutics by design, Nature Reviews Immunology, vol.421, issue.5, pp.343-57, 2006.
DOI : 10.1038/nri1837

A. Casadevall, E. Dadachova, and L. A. Pirofski, Passive antibody therapy for infectious diseases, Nature Reviews Microbiology, vol.25, issue.9, pp.695-703, 2004.
DOI : 10.1056/NEJM199311183292102

P. Chames and D. Baty, Bispecific antibodies for cancer therapy, mAbs, vol.47, issue.6, pp.276-83, 2009.
DOI : 10.1158/1078-0432.CCR-07-1488
URL : https://hal.archives-ouvertes.fr/inserm-00448211

P. Chames and D. Baty, [The future of antibody fragments, made of a single immunoglobulin domain, Med Sci, pp.25-1159, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00443810

P. Chames, M. Van-regenmortel, E. Weiss, and D. Baty, Therapeutic antibodies: successes, limitations and hopes for the future, British Journal of Pharmacology, vol.163, issue.2, pp.157-220, 2009.
DOI : 10.1111/j.1476-5381.2009.00190.x

K. Chen and A. Cerutti, The function and regulation of immunoglobulin D, Current Opinion in Immunology, vol.23, issue.3, pp.345-52, 2011.
DOI : 10.1016/j.coi.2011.01.006

W. Cheuk, K. O. Wong, C. S. Wong, and J. K. Chan, Consistent Immunostaining for Cyclin D1 Can Be Achieved on a Routine Basis Using a Newly Available Rabbit Monoclonal Antibody, The American Journal of Surgical Pathology, vol.28, issue.6, pp.28-801, 2004.
DOI : 10.1097/01.pas.0000126054.95798.94

E. H. Choy, B. Hazleman, M. Smith, L. Moss, D. G. Lisi et al., Efficacy of a novel PEGylated humanized anti-TNF fragment (CDP870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escalating trial, Rheumatology, vol.41, issue.10, pp.41-1133, 2002.
DOI : 10.1093/rheumatology/41.10.1133

T. Clackson, H. R. Hoogenboom, A. D. Griffiths, and G. Winter, Making antibody fragments using phage display libraries, Nature, vol.352, issue.6336, pp.624-632, 1991.
DOI : 10.1038/352624a0

T. P. Clackson, Genetically engineered monoclonal antibodies, Br J Rheumatol, issue.2, pp.36-45, 1991.

O. Cochet and M. Chartrain, Producing several hundred of kilograms of monoclonal antibodies for therapy: a constant challenge, Med Sci, pp.25-1078, 2009.

R. L. Coffman, D. A. Lebman, and P. Rothman, Mechanism and Regulation of Immunoglobulin Isotype Switching, Adv Immunol, pp.54-229, 1993.
DOI : 10.1016/S0065-2776(08)60536-2

P. Colque-navarro, G. Jacobsson, R. Andersson, J. I. Flock, and R. Möllby, Levels of Antibody against 11 Staphylococcus aureus Antigens in a Healthy Population, Clinical and Vaccine Immunology, vol.17, issue.7, pp.17-1117, 2010.
DOI : 10.1128/CVI.00506-09

A. B. Cosimi, R. C. Burton, R. B. Colvin, G. Goldstein, F. L. Delmonico et al., TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODY, Transplantation, vol.32, issue.6, pp.32-535, 1981.
DOI : 10.1097/00007890-198112000-00018

N. A. Cowell, M. T. Hansen, A. J. Langley, T. M. Graham, and J. R. Bates, Outbreak of staphylococcal enterotoxin food poisoning, Commun Dis Intell, pp.26-574, 2002.

L. Danielsson, S. A. Möller, and C. A. Borrebaeck, Effect of cytokines on specific in vitro immunization of human peripheral B lymphocytes against T-cell dependent antigens, Immunology, pp.61-51, 1987.

A. Datta-mannan, D. R. Witcher, Y. Tang, J. Watkins, and V. J. Wroblewski, Monoclonal Antibody Clearance: IMPACT OF MODULATING THE INTERACTION OF IgG WITH THE NEONATAL Fc RECEPTOR, Journal of Biological Chemistry, vol.282, issue.3, pp.282-1709, 2007.
DOI : 10.1074/jbc.M607161200

M. M. Davis and P. J. Bjorkman, T-cell antigen receptor genes and T-cell recognition, Nature, vol.334, issue.6181, pp.395-402, 1988.
DOI : 10.1038/334395a0

A. I. Dayton, J. G. Sodroski, C. A. Rosen, W. C. Goh, and W. A. Haseltine, The trans-activator gene of the human T cell lymphotropic virus type III is required for replication, Cell, vol.44, issue.6, pp.44-941, 1986.
DOI : 10.1016/0092-8674(86)90017-6

E. K. Deenick, J. Hasbold, and P. D. Hodgkin, Decision criteria for resolving isotype switching conflicts by B cells, European Journal of Immunology, vol.171, issue.10, pp.35-2949, 2005.
DOI : 10.1002/eji.200425719

S. K. Dessain, S. P. Adekar, J. B. Stevens, K. A. Carpenter, M. L. Skorski et al., High efficiency creation of human monoclonal antibodyproducing hybridomas, J Immunol Methods, pp.291-109, 2004.

M. M. Dinges, P. M. Orwin, and P. M. Schlievert, Exotoxins of Staphylococcus aureus, Clinical Microbiology Reviews, vol.13, issue.1, pp.16-34, 2000.
DOI : 10.1128/CMR.13.1.16-34.2000

P. Drevet, C. Lemaire, S. Gasparini, S. Zinn-justin, E. Lajeunesse et al., High-Level Production and Isotope Labeling of Snake Neurotoxins, Disulfide-Rich Proteins, Protein Expression and Purification, vol.10, issue.3, pp.293-300, 1997.
DOI : 10.1006/prep.1997.0740

A. Dryla, S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger et al., Comparison of Antibody Repertoires against Staphylococcus aureus in Healthy Individuals and in Acutely Infected Patients, Clinical and Vaccine Immunology, vol.12, issue.3, pp.12-387, 2005.
DOI : 10.1128/CDLI.12.3.387-398.2005

O. Dubreuil, B. Muller, M. Bossus, A. Savatier, and F. Ducancel, [Directed molecular evolution of antibodies], J Soc Biol, pp.355-63, 0200.

D. D. Dudley, J. Chaudhuri, C. H. Bassing, and F. W. Alt, Mechanism and Control of V(D)J Recombination versus Class Switch Recombination: Similarities and Differences, Adv Immunol, issue.86, pp.43-112, 2005.
DOI : 10.1016/S0065-2776(04)86002-4

M. Dueñas, L. T. Chin, A. C. Malmborg, R. Casalvilla, M. Ohlin et al., In vitro immunization of naive human B cells yields high affinity immunoglobulin G antibodies as illustrated by phage display, Immunology, vol.89, issue.1, pp.89-90, 1996.
DOI : 10.1046/j.1365-2567.1996.d01-708.x

C. A. Dutertre and J. L. Teillaud, [Monoclonal antibodies, act two: new molecules for new challenges], J Soc Biol, pp.377-86, 0200.

L. Edelman, C. Margaritte, H. Chaabihi, E. Monchâtre, D. Blanchard et al., Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system, Immunology, vol.91, issue.1, pp.91-104, 1997.
DOI : 10.1046/j.1365-2567.1997.00219.x

M. M. Eibl, History of Immunoglobulin Replacement, Immunology and Allergy Clinics of North America, vol.28, issue.4, pp.737-64, 2008.
DOI : 10.1016/j.iac.2008.06.004

D. Emanuel, J. Gold, J. Colacino, C. Lopez, and U. Hammerling, A human monoclonal antibody to cytomegalovirus (CMV), J Immunol, issue.133, pp.2202-2207, 1984.

R. Alvarez, G. Tambussi, C. Tassan-din, G. Palamara, A. Latini et al., The preventive phase I trial with the HIV-1 Tat-based vaccine, pp.28-371, 2009.

D. A. Erb and H. A. Nabi, Clinical and technical considerations for imaging colorectal cancers with technetium-99m-labeled antiCEA Fab' fragment, J Nucl Med Technol, vol.21, pp.28-40, 2000.

M. L. Evenson, M. W. Hinds, R. S. Bernstein, and M. S. Bergdoll, Estimation of human dose of staphylococcal enterotoxin A from a large outbreak of staphylococcal food poisoning involving chocolate milk, International Journal of Food Microbiology, vol.7, issue.4, pp.311-317, 1988.
DOI : 10.1016/0168-1605(88)90057-8

C. Fromen-romano, P. Drevet, A. Robert, A. Ménez, and M. Léonetti, Recombinant Staphylococcus strains as live vectors for the induction of neutralizing anti-diphtheria toxin antisera, Infect Immun, pp.67-5007, 1999.

W. Fu, B. E. Sanders-beer, K. S. Katz, D. R. Maglott, K. D. Pruitt et al., Human immunodeficiency virus type 1, human protein interaction database at NCBI, Nucleic Acids Research, vol.37, issue.Database, pp.37-417, 2009.
DOI : 10.1093/nar/gkn708

A. Gadzinski, D. Matz, E. Favre, and M. Léonetti, Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens, Vaccine, vol.30, issue.18, pp.30-2859, 2012.
DOI : 10.1016/j.vaccine.2012.02.042

K. A. Gelderman, S. Tomlinson, G. D. Ross, and A. Gorter, Complement function in mAbmediated cancer immunotherapy, Trends Immunol, pp.25-158, 2004.

D. R. Getts, M. T. Getts, D. P. Mccarthy, E. M. Chastain, and S. D. Miller, Have we overestimated the benefit of human(ized) antibodies?, mAbs, vol.32, issue.6, pp.682-94, 2010.
DOI : 10.1056/NEJMoa0810603

D. M. Gill, Bacterial toxins: a table of lethal amounts, Microbiol Rev, issue.46, pp.86-94, 1982.

C. C. Goodnow, Balancing Immunity, Autoimmunity, and Self-tolerance, Annals of the New York Academy of Sciences, vol.268, issue.1 B-Lymphocytes, pp.815-55, 1997.
DOI : 10.1016/1074-7613(95)90179-5

C. C. Goodnow and J. G. Cyster, Lymphocyte homing: The scent of a follicle, Current Biology, vol.7, issue.4, pp.219-241, 1997.
DOI : 10.1016/S0960-9822(06)00105-9

H. Gram, L. A. Marconi, C. F. Barbas, T. A. Collet, R. A. Lerner et al., In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library., Proceedings of the National Academy of Sciences, vol.89, issue.8, pp.89-3576, 1992.
DOI : 10.1073/pnas.89.8.3576

J. Grassi, Y. Frobert, P. Pradelles, F. Chercuitte, D. Gruaz et al., Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media, J Immunol Methods, issue.123, pp.193-210, 1989.

R. Grunow, S. Jahn, T. Porstmann, S. S. Kiessig, H. Steinkellner et al., The high efficiency, human B cell immortalizing heteromyeloma CB-F7. Production of human monoclonal antibodies to human immunodeficiency virus, J Immunol Methods, issue.106, pp.257-65, 1988.

J. F. Haeuw, V. Caussanel, and A. Beck, [Immunoconjugates, drug-armed antibodies to fight against cancer, Med Sci, pp.25-1046, 2009.

A. R. Hamad, P. Marrack, and J. W. Kappler, Transcytosis of Staphylococcal Superantigen Toxins, The Journal of Experimental Medicine, vol.253, issue.8, pp.1447-54, 1997.
DOI : 10.3109/10408419009105728

M. M. Harmsen, H. J. De, and . Haard, Properties, production, and applications of camelid singledomain antibody fragments, Appl Microbiol Biotechnol, pp.77-90, 2007.

R. E. Hawkins, S. J. Russell, and G. Winter, Selection of phage antibodies by binding affinity. Mimicking affinity maturation, J Mol Biol, pp.226-889, 1992.

P. R. Hinton, M. G. Johlfs, J. M. Xiong, K. Hanestad, K. C. Ong et al., Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates, Journal of Biological Chemistry, vol.279, issue.8, pp.279-6213, 2004.
DOI : 10.1074/jbc.C300470200

H. H. Hogrefe, J. R. Amberg, B. N. Hay, J. A. Sorge, and B. Shopes, Cloning in a bacteriophage lambda vector for the display of binding proteins on filamentous phage, Gene, vol.137, issue.1, pp.137-85, 1993.
DOI : 10.1016/0378-1119(93)90255-2

H. H. Hogrefe, R. L. Mullinax, A. E. Lovejoy, B. N. Hay, and J. A. Sorge, A bacteriophage lambda vector for the cloning and expression of immunoglobulin Fab fragments on the surface of filamentous phage, Gene, vol.128, issue.1, pp.128-119, 1993.
DOI : 10.1016/0378-1119(93)90162-V

L. V. Holdeman, The Ecology and Natural History of Clostridium botulinum, Journal of Wildlife Diseases, vol.6, issue.4, pp.205-215, 1970.
DOI : 10.7589/0090-3558-6.4.205

H. R. Hoogenboom, Selecting and screening recombinant antibody libraries, Nature Biotechnology, vol.91, issue.9, pp.1105-1121, 2005.
DOI : 10.1093/nar/gnh030

C. L. Hornick and F. Karuch, Antibody affinity. 3. The role of multivalance: Immunochemistry, v, pp.325-365, 1972.

Z. Huang, W. Zhu, G. Szekeres, and H. Xia, Development of New Rabbit Monoclonal Antibody to Estrogen Receptor, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.1, pp.13-91, 2005.
DOI : 10.1097/00129039-200503000-00015

W. Y. Hwang and J. Foote, Immunogenicity of engineered antibodies, Methods, vol.36, issue.1, pp.3-10, 2005.
DOI : 10.1016/j.ymeth.2005.01.001

A. Ichikawa, Y. Katakura, K. Teruya, S. Hashizume, and S. Shirahata, In vitro immunization of human peripheral blood lymphocytes: establishment of B cell lines secreting IgM specific for cholera toxin B subunit from lymphocytes stimulated with IL-2 and IL-4, pp.31-133, 1999.

K. James and G. T. Bell, Human monoclonal antibody production. Current status and future prospects, J Immunol Methods, issue.100, pp.5-40, 1987.
DOI : 10.1016/0022-1759(87)90170-0

S. Jarraud, M. A. Peyrat, A. Lim, A. Tristan, M. Bes et al., egc, A Highly Prevalent Operon of Enterotoxin Gene, Forms a Putative Nursery of Superantigens in Staphylococcus aureus, The Journal of Immunology, vol.166, issue.1, pp.669-77, 2001.
DOI : 10.4049/jimmunol.166.1.669

R. Jefferis, Antibody therapeutics:, Expert Opinion on Biological Therapy, vol.355, issue.9, pp.1401-1414, 2007.
DOI : 10.1016/S0002-9343(02)01243-3

X. R. Jiang, A. Song, S. Bergelson, T. Arroll, B. Parekh et al., Advances in the assessment and control of the effector functions of therapeutic antibodies, Nature Reviews Drug Discovery, vol.45, issue.2, pp.101-112, 2011.
DOI : 10.1038/nrd3365

E. A. Johnson and M. Bradshaw, Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective, Toxicon, vol.39, issue.11, pp.1703-1725, 2001.
DOI : 10.1016/S0041-0101(01)00157-X

H. M. Johnson, J. K. Russell, and C. H. Pontzer, Staphylococcal enterotoxin microbial superantigens, FASEB J, issue.5, pp.2706-2718, 1991.
DOI : 10.3181/00379727-198-43321a

M. K. Johri, R. Mishra, C. Chhatbar, S. K. Unni, and S. K. Singh, Tits and bits of HIV Tat protein, Expert Opinion on Biological Therapy, vol.128, issue.3, pp.269-83, 2011.
DOI : 10.1073/pnas.87.9.3479

P. T. Jones, P. H. Dear, J. Foote, M. S. Neuberger, and G. Winter, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, vol.312, issue.6069, pp.321-522, 1986.
DOI : 10.1038/321522a0

Y. S. Jung, S. E. Matsumoto, Y. Katakura, M. Yamashita, K. Tomimatsu et al., Generation of human monoclonal antibodies against Propionibacterium acnes by applying the phage display method to human peripheral blood mononuclear cells immunized in??vitro, Cytotechnology, vol.40, issue.2, pp.57-169, 2008.
DOI : 10.1007/s10616-008-9138-z

Y. Kanda, N. Yamane-ohnuki, N. Sakai, K. Yamano, R. Nakano et al., Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCC, Biotechnology and Bioengineering, vol.87, issue.4, pp.94-680, 2006.
DOI : 10.1002/bit.20880

J. Kappler, J. White, H. Kozono, J. Clements, and P. Marrack, Binding of a soluble alpha beta T-cell receptor to superantigen/major histocompatibility complex ligands., Proceedings of the National Academy of Sciences, vol.91, issue.18, pp.91-8462, 1994.
DOI : 10.1073/pnas.91.18.8462

J. W. Kappler, A. Herman, J. Clements, and P. Marrack, Mutations defining functional regions of the superantigen staphylococcal enterotoxin B, Journal of Experimental Medicine, vol.175, issue.2, pp.175-387, 1992.
DOI : 10.1084/jem.175.2.387

M. A. Keller and E. R. Stiehm, Passive Immunity in Prevention and Treatment of Infectious Diseases, Clinical Microbiology Reviews, vol.13, issue.4, pp.602-616, 2000.
DOI : 10.1128/CMR.13.4.602-614.2000

D. Kozbor, D. Dexter, and J. C. Roder, A Comparative Analysis of the Phenotypic Characteristics of Available Fusion Partners for the Construction of Human Hybridomas, Hybridoma, vol.2, issue.1, pp.7-16, 1983.
DOI : 10.1089/hyb.1983.2.7

D. Kozbor, A. E. Lagarde, and J. C. Roder, Human hybridomas constructed with antigenspecific Epstein-Barr virus-transformed cell lines, Proc Natl Acad Sci, pp.79-6651, 1982.

D. Kozbor and J. C. Roder, Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique, J Immunol, pp.127-1275, 1981.

D. Kozbor, J. C. Roder, T. H. Chang, Z. Steplewski, and H. Koprowski, Human Anti-Tetanus Toxoid Monoclonal Antibody Secreted by EBV-Transformed Human B Cells Fused with Murine Myeloma, Hybridoma, vol.1, issue.3, pp.323-331, 1982.
DOI : 10.1089/hyb.1.1982.1.323

R. J. Kreitman, Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies, Current Pharmaceutical Design, vol.15, issue.23, pp.2652-64, 2009.
DOI : 10.2174/138161209788923949

T. Kudo, A. Asao, and T. Tachibana, Highly efficient procedure for production of human monoclonal antibodies: Establishment of hybrids between Epstein-Barr virus-transformed B lymphocytes and heteromyeloma cells by use of GIT culture medium., The Tohoku Journal of Experimental Medicine, vol.154, issue.4, pp.154-345, 1988.
DOI : 10.1620/tjem.154.345

G. Köhler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-502, 1975.
DOI : 10.1038/256495a0

P. J. Lachmann, The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens, Immunochemistry, issue.8, pp.81-89, 1971.

J. Lagacé and B. R. Brodeur, Parameters affecting in vitro immunization of human lymphocytes, Journal of Immunological Methods, vol.85, issue.1, pp.85-127, 1985.
DOI : 10.1016/0022-1759(85)90281-9

H. Lai, M. Engle, A. Fuchs, T. Keller, S. Johnson et al., Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice, Proceedings of the National Academy of Sciences, vol.107, issue.6, pp.2419-2443, 2010.
DOI : 10.1073/pnas.0914503107

E. A. Larkin, B. G. Stiles, and R. G. Ulrich, Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B, PLoS ONE, vol.63, issue.10, p.13253, 2010.
DOI : 10.1371/journal.pone.0013253.t004

G. A. Lazar, W. Dang, S. Karki, O. Vafa, J. S. Peng et al., Engineered antibody Fc variants with enhanced effector function, Proc Natl Acad Sci U S A, v. 103, pp.4005-4015, 2006.
DOI : 10.1073/pnas.0508123103

L. Loir, Y. , F. Baron, and M. Gautier, Staphylococcus aureus and food poisoning, Genet Mol Res, issue.2, pp.63-76, 2003.

S. G. Ler, F. K. Lee, and P. Gopalakrishnakone, Trends in detection of warfare agents. Detection methods for ricin, staphylococcal enterotoxin B and T-2 toxin, J Chromatogr A, pp.1133-1134, 2006.

G. Lina, G. A. Bohach, S. P. Nair, K. Hiramatsu, E. Jouvin-marche et al., Standard nomenclature for the superantigens expressed by Staphylococcus, C. f. S. Superantigens J Infect Dis, pp.189-2334, 2004.

B. R. Line, R. J. Breyer, K. D. Mcelvany, D. C. Earle, and M. B. Khazaeli, Evaluation of human anti-mouse antibody response in normal volunteers following repeated injections of fanolesomab (NeutroSpec), a murine anti???CD15 IgM monoclonal antibody for imaging infection, Nuclear Medicine Communications, vol.25, issue.8, pp.25-807, 2004.
DOI : 10.1097/01.mnm.0000134745.22032.49

N. Lonberg, Human antibodies from transgenic animals, Nature Biotechnology, vol.55, issue.9, pp.1117-1142, 2005.
DOI : 10.1038/ng1373

F. D. Lowy, Staphylococcus aureus infections, N Engl J Med, issue.339, pp.520-552, 1998.

A. H. Lucas and D. C. Reason, Polysaccharide vaccines as probes of antibody repertoires in man, Immunological Reviews, vol.150, issue.1, pp.89-104, 1999.
DOI : 10.1016/0022-2836(87)90412-8

M. Léonetti, A. Gadzinski, and G. Moine, Cell Surface Heparan Sulfate Proteoglycans Influence MHC Class II-Restricted Antigen Presentation, The Journal of Immunology, vol.185, issue.7, pp.185-3847, 2010.
DOI : 10.4049/jimmunol.0902724

M. Léonetti, R. Thai, J. Cotton, S. Leroy, P. Drevet et al., Increasing immunogenicity of antigens fused to Ig-binding proteins by cell surface targeting, J Immunol, pp.160-3820, 1998.

J. P. Mach, S. Carrel, C. Merenda, B. Sordat, and J. C. Cerottini, In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice, Nature, vol.175, issue.5450, pp.248-704, 1974.
DOI : 10.1038/248704a0

J. P. Mach, J. F. Chatal, J. D. Lumbroso, F. Buchegger, M. Forni et al., Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma, Cancer Res, pp.43-5593, 1983.

N. Mahant, P. D. Clouston, and I. T. Lorentz, The current use of botulinum toxin, Journal of Clinical Neuroscience, vol.7, issue.5, pp.389-94, 2000.
DOI : 10.1054/jocn.2000.0684

W. A. Marasco and J. Sui, The growth and potential of human antiviral monoclonal antibody therapeutics, Nature Biotechnology, vol.49, issue.12, pp.1421-1455, 2007.
DOI : 10.1016/S0022-1759(99)00223-9

R. A. Mariuzza, S. E. Phillips, and R. J. Poljak, The structural basis of antigen-antibody recognition, Annu Rev Biophys Biophys Chem, issue.16, pp.139-59, 1987.

J. D. Marks, H. R. Hoogenboom, T. P. Bonnert, J. Mccafferty, A. D. Griffiths et al., By-passing immunization. Human antibodies from V-gene libraries displayed on phage, J Mol Biol, pp.222-581, 1991.

P. Marrack, M. Blackman, E. Kushnir, and J. Kappler, The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells, Journal of Experimental Medicine, vol.171, issue.2, pp.171-455, 1990.
DOI : 10.1084/jem.171.2.455

S. E. Matsumoto, M. Yamashita, Y. Katakura, E. Noguchi, Y. Aiba et al., In vitro immunization can elicit the expansion of diverse repertoire of B cells from peripheral blood mononuclear cells, Cytotechnology, vol.40, issue.3, pp.52-227, 2006.
DOI : 10.1007/s10616-006-9003-x

M. E. Mattix, R. E. Hunt, C. L. Wilhelmsen, A. J. Johnson, and W. B. Baze, Aerosolized Staphylococcal Enterotoxin B-Induced Pulmonary Lesions in Rhesus Monkeys (Macaca mulatta), Toxicologic Pathology, vol.23, issue.3, pp.262-270, 1995.
DOI : 10.1177/019262339502300304

J. A. Maynard, C. B. Maassen, S. H. Leppla, K. Brasky, J. L. Patterson et al., Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity, Nature Biotechnology, vol.20, issue.6, pp.20-597, 2002.
DOI : 10.1038/nbt0602-597

C. Mazuet, J. Dano, M. R. Popoff, C. Créminon, and H. Volland, Characterization of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-Lives on Therapeutic Activity, PLoS ONE, vol.13, issue.8, p.12416, 2010.
DOI : 10.1371/journal.pone.0012416.s003

J. Mccafferty, A. D. Griffiths, G. Winter, and D. J. , Phage antibodies: filamentous phage displaying antibody variable domains, Nature, vol.348, issue.6301, pp.348-552, 1990.
DOI : 10.1038/348552a0

I. S. Mian, A. R. Bradwell, and A. J. Olson, Structure, function and properties of antibody binding sites, Journal of Molecular Biology, vol.217, issue.1, pp.217-133, 1991.
DOI : 10.1016/0022-2836(91)90617-F

S. R. Monday and G. A. Bohach, Use of multiplex PCR to detect classical and newly described pyrogenic toxin genes in staphylococcal isolates, J Clin Microbiol, pp.37-3411, 1999.

G. L. Moore, H. Chen, S. Karki, and G. A. Lazar, Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions, mAbs, vol.9, issue.2, pp.181-190, 2010.
DOI : 10.1038/35018508

S. L. Morrison, M. J. Johnson, L. A. Herzenberg, and V. T. Oi, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains., Proceedings of the National Academy of Sciences, vol.81, issue.21, pp.81-6851, 1984.
DOI : 10.1073/pnas.81.21.6851

M. Muramatsu, K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai et al., Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme, Cell, vol.102, issue.5, pp.553-63, 2000.
DOI : 10.1016/S0092-8674(00)00078-7
URL : http://doi.org/10.1016/s0092-8674(00)00078-7

G. P. Murphy, P. B. Snow, J. Brandt, A. Elgamal, and M. K. Brawer, Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint??? scintiscans, Prostate, v. 42, pp.145-154, 2000.
DOI : 10.1002/(SICI)1097-0045(20000201)42:2<145::AID-PROS9>3.0.CO;2-Q

A. Nechansky, HAHA--nothing to laugh about Measuring the immunogenicity (human antihuman antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology, J Pharm Biomed Anal, pp.51-252, 2010.

F. Nimmerjahn and J. V. Ravetch, Fcgamma receptors as regulators of immune responses, Nat Rev Immunol, issue.8, pp.34-47, 2008.

F. Nimmerjahn and J. V. Ravetch, Antibody-mediated modulation of immune responses, Immunological Reviews, vol.109, issue.Suppl., pp.265-75, 2010.
DOI : 10.1111/j.1600-065X.2010.00910.x

A. Nowakowski, C. Wang, D. B. Powers, P. Amersdorfer, T. J. Smith et al., Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody, Proceedings of the National Academy of Sciences, vol.99, issue.17, pp.99-11346, 2002.
DOI : 10.1073/pnas.172229899

O. 'brien, S. M. , H. Kantarjian, D. A. Thomas, F. J. Giles et al., Rituximab dose-escalation trial in chronic lymphocytic leukemia, J Clin Oncol, pp.19-2165, 2001.

Y. Okada, Analysis of giant polynuclear cell formation caused by HVJ virus from Ehrlich's ascites tumor cells. I. Microscopic observation of giant polynuclear cell formation, Exp Cell Res, pp.98-107, 1962.

S. Olivier, M. Jacoby, C. Brillon, S. Bouletreau, T. Mollet et al., EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity, mAbs, vol.139, issue.4, p.66, 2010.
DOI : 10.1074/jbc.M510171200

S. Olivier and M. Mehtali, Alternative production systems for therapeutic monoclonal antibodies, Med Sci, pp.1163-1171, 2009.

M. Paizi, D. Zivion, and G. Spira, Use of Mutagens to Increase Rate of Immunoglobulin Isotype Switching of Hybridoma Cells, Hybridoma, vol.14, issue.1, pp.85-90, 1995.
DOI : 10.1089/hyb.1995.14.85

M. Pallardy, Toxic effects and use of therapeutic monoclonal antibodies], Med Sci, pp.1130-1134, 2009.

A. C. Papageorgiou and K. R. Acharya, Microbial superantigens: from structure to function, Trends in Microbiology, vol.8, issue.8, pp.369-75, 2000.
DOI : 10.1016/S0966-842X(00)01793-5

A. C. Papageorgiou, H. S. Tranter, and K. R. Acharya, Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 ?? resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors, Journal of Molecular Biology, vol.277, issue.1, pp.277-61, 1998.
DOI : 10.1006/jmbi.1997.1577

K. A. Pape, D. M. Catron, A. A. Itano, and M. K. Jenkins, The Humoral Immune Response Is Initiated in Lymph Nodes by B Cells that Acquire Soluble Antigen Directly in the Follicles, Immunity, vol.26, issue.4, pp.26-491, 2007.
DOI : 10.1016/j.immuni.2007.02.011

L. Pinkas, P. D. Robins, L. A. Forstrom, D. W. Mahoney, and B. P. Mullan, Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature, Nuclear Medicine Communications, vol.20, issue.8, pp.20-689, 1999.
DOI : 10.1097/00006231-199908000-00002

S. A. Plotkin, Vaccines: Correlates of Vaccine???Induced Immunity, Clinical Infectious Diseases, vol.47, issue.3, pp.47-401, 2008.
DOI : 10.1086/589862

G. Pocsfalvi, G. Cacace, M. Cuccurullo, G. Serluca, A. Sorrentino et al., Proteomic analysis of exoproteins expressed by enterotoxigenic Staphylococcus aureus strains, PROTEOMICS, vol.73, issue.12, pp.2462-76, 2008.
DOI : 10.1002/pmic.200700965

H. Poras, T. Ouimet, S. V. Orng, M. C. Fournié-zaluski, M. R. Popoff et al., Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay, Applied and Environmental Microbiology, vol.75, issue.13, pp.75-4382, 2009.
DOI : 10.1128/AEM.00091-09

R. R. Porter, A chemical study of rabbit antiovalbumin, Biochemical Journal, vol.46, issue.4, pp.473-481, 1950.
DOI : 10.1042/bj0460473

R. R. Porter, The formation of a specific inhibitor by hydrolysis of rabbit antiovalbumin, Biochemical Journal, vol.46, issue.4, pp.479-84, 1950.
DOI : 10.1042/bj0460479

M. C. Potter, Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants, Nature, vol.107, issue.4820, pp.1086-1093, 1962.
DOI : 10.1038/1931086a0

B. Poulain and Y. Humeau, [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect], Ann Readapt Med Phys, pp.46-265, 2003.

F. J. Primus, R. H. Wang, D. M. Goldenberg, and H. J. Hansen, Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen, Cancer Res, pp.33-2977, 1973.

R. G. Ptak, W. Fu, B. E. Sanders-beer, J. E. Dickerson, J. W. Pinney et al., Cataloguing the HIV type 1 human protein interaction network, AIDS Res Hum Retroviruses, pp.24-1497, 2008.

J. Pène, J. F. Gauchat, S. Lécart, E. Drouet, P. Guglielmi et al., Cutting Edge: IL-21 Is a Switch Factor for the Production of IgG1 and IgG3 by Human B Cells, The Journal of Immunology, vol.172, issue.9, pp.172-5154, 2004.
DOI : 10.4049/jimmunol.172.9.5154

J. M. Reichert, Antibody-based therapeutics to watch in 2011, mAbs, vol.6, issue.1, pp.76-99, 2011.
DOI : 10.1182/blood-2009-08-239665

J. M. Reichert, A. Beck, and H. Iyer, European Medicines Agency workshop on biosimilar monoclonal antibodies, mAbs, vol.3437, issue.5, pp.394-416, 2009.
DOI : 10.1038/nrd2532

J. M. Reichert, C. J. Rosensweig, L. B. Faden, and M. C. Dewitz, Monoclonal antibody successes in the clinic, Nature Biotechnology, vol.101, issue.9, pp.1073-1081, 2005.
DOI : 10.1038/nrd1470

J. C. Roder, S. P. Cole, and D. Kozbor, The EBV-hybridoma technique: Methods Enzymol, pp.140-67, 1986.

M. A. Roguska, J. T. Pedersen, C. A. Keddy, A. H. Henry, S. J. Searle et al., Humanization of murine monoclonal antibodies through variable domain resurfacing., Proceedings of the National Academy of Sciences, vol.91, issue.3, pp.91-969, 1994.
DOI : 10.1073/pnas.91.3.969

S. Rossi, L. Laurino, A. Furlanetto, S. Chinellato, E. Orvieto et al., Rabbit Monoclonal Antibodies, American Journal of Clinical Pathology, vol.124, issue.2, pp.124-295, 2005.
DOI : 10.1309/NR8HN08GDPVEMU08

A. Rosén and G. Klein, UV light-induced immunoglobulin heavy-chain class switch in a human lymphoblastoid cell line, Nature, vol.8, issue.5939, pp.189-90, 1983.
DOI : 10.1038/306189a0

J. Rousseaux, R. Rousseaux-prevost, and H. Bazin, [63] Optimal conditions for the preparation of proteolytic fragments from monoclonal IgG of different rat IgG subclasses, Methods Enzymol, pp.121-663, 1986.
DOI : 10.1016/0076-6879(86)21065-4

L. Sarda, P. Colin, F. Boccara, D. Daou, R. Lebtahi et al., Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms, Journal of the American College of Cardiology, vol.37, issue.3, pp.37-786, 2001.
DOI : 10.1016/S0735-1097(00)01201-8

R. Sarnovsky, T. Tendler, M. Makowski, M. Kiley, A. Antignani et al., Initial characterization of an immunotoxin constructed from domains II and III of cholera exotoxin, Cancer Immunology, Immunotherapy, vol.268, issue.5, pp.59-737, 2010.
DOI : 10.1007/s00262-009-0794-4

R. M. Schaaper, Mechanisms of mutagenesis in the Escherichia coli mutator mutD5: role of DNA mismatch repair., Proceedings of the National Academy of Sciences, vol.85, issue.21, pp.85-8126, 1988.
DOI : 10.1073/pnas.85.21.8126

H. W. Schroeder and L. Cavacini, Structure and function of immunoglobulins, Journal of Allergy and Clinical Immunology, vol.125, issue.2, pp.41-52, 2010.
DOI : 10.1016/j.jaci.2009.09.046

R. W. Schroff, K. A. Foon, S. M. Beatty, R. K. Oldham, and A. C. Morgan, Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy, Cancer Res, pp.45-879, 1985.

J. Schwaber and E. P. Cohen, Human ?? Mouse Somatic Cell Hybrid Clone secreting Immunoglobulins of both Parental Types, Nature, vol.162, issue.5416, pp.444-451, 1973.
DOI : 10.1038/244444a0

R. L. Shields, A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae et al., High resolution mapping of the binding site on human IgG1 for Fc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the Fc gamma R, J Biol Chem, pp.276-6591, 2001.

T. Shinkawa, K. Nakamura, N. Yamane, E. Shoji-hosaka, Y. Kanda et al., The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity, Journal of Biological Chemistry, vol.278, issue.5, pp.278-3466, 2003.
DOI : 10.1074/jbc.M210665200

S. Siberil, C. A. Dutertre, C. Boix, and J. L. Teillaud, Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes], Transfus Clin Biol, pp.12-114, 2005.

C. P. Simmons, N. L. Bernasconi, A. L. Suguitan, K. Mills, J. M. Ward et al., Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza, PLoS Medicine, vol.8, issue.5, p.178, 2007.
DOI : 10.1371/journal.pmed.0040178.t002

J. Smolens, A. B. Vogt, M. N. Crawford, and &. J. Stokes, The persistence in the human circulation of horse and human tetanus antitoxins, The Journal of Pediatrics, vol.59, issue.6, pp.899-902, 1961.
DOI : 10.1016/S0022-3476(61)80320-X

H. Spieker-polet, P. Sethupathi, P. C. Yam, and K. L. Knight, Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas., Proceedings of the National Academy of Sciences, vol.92, issue.20, pp.92-9348, 1995.
DOI : 10.1073/pnas.92.20.9348

G. Spira, M. Paizi, S. Mazar, G. Nussbaum, S. Mukherjee et al., Generation of biologically active anti-Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis, Clinical and Experimental Immunology, vol.105, issue.3, pp.105-436, 1996.
DOI : 10.1046/j.1365-2249.1996.d01-786.x

M. Steinitz, Three decades of human monoclonal antibodies: past, present and future developments, Hum Antibodies, issue.18, pp.1-10, 2009.

M. Steinitz, S. Koskimies, G. Klein, and O. Mäkelä, Establishment of specific antibody producing human lines by antigen preselection and Epstein-Barr virus (EBV)-transformation, J Clin Lab Immunol, issue.2, pp.1-7, 1979.

B. G. Stiles, A. R. Garza, R. G. Ulrich, and J. W. Boles, Mucosal Vaccination with Recombinantly Attenuated Staphylococcal Enterotoxin B and Protection in a Murine Model, Infection and Immunity, vol.69, issue.4, pp.69-2031, 2001.
DOI : 10.1128/IAI.69.4.2031-2036.2001

K. D. Stone, C. Prussin, and D. D. Metcalfe, IgE, mast cells, basophils, and eosinophils, Journal of Allergy and Clinical Immunology, vol.125, issue.2, pp.125-73, 2010.
DOI : 10.1016/j.jaci.2009.11.017
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847274

M. R. Straka, J. M. Joyce, and D. T. Myers, Tc-99m Nofetumomab Merpentan Complements an Equivocal Bone Scan for Detecting Skeletal Metastatic Disease From Lung Cancer, Clinical Nuclear Medicine, vol.25, issue.1, pp.25-54, 2000.
DOI : 10.1097/00003072-200001000-00013

W. R. Strohl, Optimization of Fc-mediated effector functions of monoclonal antibodies, Current Opinion in Biotechnology, vol.20, issue.6, pp.685-91, 2009.
DOI : 10.1016/j.copbio.2009.10.011

C. O. Tacket, W. X. Shandera, J. M. Mann, N. T. Hargrett, and P. A. Blake, Equine antitoxin use and other factors that predict outcome in type A foodborne botulism, The American Journal of Medicine, vol.76, issue.5, pp.76-794, 1984.
DOI : 10.1016/0002-9343(84)90988-4

B. Tang, S. Yu, M. Zheng, F. Ding, R. Zhao et al., High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice, Transgenic Research, vol.80, issue.4, pp.17-727, 2008.
DOI : 10.1007/s11248-007-9162-3

J. L. Teeling, R. R. French, M. S. Cragg, J. Van-den-brakel, M. Pluyter et al., Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas, Blood, vol.104, issue.6, pp.1793-800, 2004.
DOI : 10.1182/blood-2004-01-0039

D. L. Thiele, M. Kurosaka, and P. E. Lipsky, Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester, J Immunol, pp.131-2282, 1983.

M. E. Tilahun, A. Kwan, K. Natarajan, M. Quinn, A. Y. Tilahun et al., Chimeric Anti-Staphylococcal Enterotoxin B Antibodies and Lovastatin Act Synergistically to Provide In Vivo Protection against Lethal Doses of SEB, PLoS ONE, vol.6, issue.11, p.27203, 2011.
DOI : 10.1371/journal.pone.0027203.g004

K. Tomimatsu, S. E. Matsumoto, M. Yamashita, K. Teruya, Y. Katakura et al., Production of human monoclonal antibodies against Fc(epsilon)RI(alpha) by a method combining in vitro immunization with phage display, Biosci Biotechnol Biochem, pp.73-1465, 2009.

M. Torres, R. May, M. D. Scharff, and A. Casadevall, Variable-Region-Identical Antibodies Differing in Isotype Demonstrate Differences in Fine Specificity and Idiotype, The Journal of Immunology, vol.174, issue.4, pp.174-2132, 2005.
DOI : 10.4049/jimmunol.174.4.2132

S. Turbant, F. Martinon, G. Moine, R. Le-grand, and M. Léonetti, Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice, Vaccine, vol.27, issue.39, pp.27-5349, 2009.
DOI : 10.1016/j.vaccine.2009.06.083

M. Tähtinen, A. Ranki, S. L. Valle, V. Ovod, and K. Krohn, B-cell epitopes in HIV-1 Tat and Rev proteins colocalize with T-cell epitopes and with functional domains, Biomedicine & Pharmacotherapy, vol.51, issue.10, pp.51-480, 1997.
DOI : 10.1016/S0753-3322(97)82330-X

R. G. Ulrich, S. Bavari, and M. A. Olson, Bacterial superantigens in human disease: structure, function and diversity, Trends in Microbiology, vol.3, issue.12, pp.463-471, 1995.
DOI : 10.1016/S0966-842X(00)89011-3

R. G. Ulrich, M. A. Olson, and S. Bavari, Development of engineered vaccines effective against structurally related bacterial superantigens, Vaccine, vol.16, issue.19, pp.1857-64, 1998.
DOI : 10.1016/S0264-410X(98)00176-5

S. Uthoff and T. Böldicke, In vitro immunization of mouse spleen cells for the production of monoclonal IgG1 antibodies using an antigen-specific T helper cell clone (D.10.G4.1), Journal of Immunological Methods, vol.166, issue.2, pp.165-75, 1993.
DOI : 10.1016/0022-1759(93)90357-D

P. H. Van-berkel, J. Gerritsen, E. Van-voskuilen, G. Perdok, T. Vink et al., Rapid production of recombinant human IgG With improved ADCC effector function in a transient expression system, Biotechnology and Bioengineering, vol.23, issue.7, pp.105-350, 2010.
DOI : 10.1002/bit.22535

R. A. Van-den-bussche, J. D. Lyon, and G. A. Bohach, Molecular Evolution of the Staphylococcal and Streptococcal Pyrogenic Toxin Gene Family, Molecular Phylogenetics and Evolution, vol.2, issue.4, pp.281-92, 1993.
DOI : 10.1006/mpev.1993.1027

E. Van-loghem and S. D. Litwin, Antigenic determinants on immunoglobulins of nonhuman primates.: Transplant Proc, pp.129-164, 1972.

D. J. Volkman, S. P. Allyn, and A. S. Fauci, Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis, J Immunol, pp.129-107, 1982.

E. S. Ward and V. Ghetie, The effector functions of immunoglobulins: implications for therapy, Ther Immunol, issue.2, pp.77-94, 1995.

E. S. Ward, J. Zhou, V. Ghetie, and R. J. Ober, Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans, International Immunology, vol.15, issue.2, pp.15-187, 2003.
DOI : 10.1093/intimm/dxg018

M. Ward, C. Lin, D. C. Victoria, B. P. Fox, J. A. Fox et al., Characterization of Humanized Antibodies Secreted by Aspergillus niger, Applied and Environmental Microbiology, vol.70, issue.5, pp.70-2567, 2004.
DOI : 10.1128/AEM.70.5.2567-2576.2004

P. Waterhouse, A. D. Griffiths, K. S. Johnson, and G. Winter, Combinatorial infection and in vivo recombination: a strategy for making large phage antibody repertoires, Nucleic Acids Res, issue.21, pp.2265-2271, 1993.

K. Wohlfarth, K. Kampe, and H. Bigalke, Pharmacokinetic properties of different formulations of botulinum neurotoxin type A, Movement Disorders, vol.58, issue.S8, pp.65-72, 2004.
DOI : 10.1002/mds.20012

G. Wohlleben, D. Gray, and A. Schimpl, In vitro immunization of naive mouse B cells: establishment of IgM secreting hybridomas specific for souble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts, Int Immunol, issue.8, pp.343-352, 1996.

B. A. Woodruff, P. M. Griffin, L. M. Mccroskey, J. F. Smart, R. B. Wainwright et al., Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, J Infect Dis, pp.1975-1988, 1992.

T. Wurch, P. Lowe, A. Beck, and N. Corvaia, Protein scaffolds as alternatives to whole antibodies: from discovery research to clinical development], Med Sci, pp.25-1169, 2009.

M. Yamashita, Y. Katakura, S. Y. Shim, S. E. Matsumoto, T. Tamura et al., Different individual immune responses elicited by in vitro immunization: Cytotechnology, v, pp.40-161, 2002.

J. Yguerabide, H. F. Epstein, and L. Stryer, Segmental flexibility in an antibody molecule, Journal of Molecular Biology, vol.51, issue.3, pp.51-573, 1970.
DOI : 10.1016/0022-2836(70)90009-4

A. Zafiropoulos, E. Andersson, E. Krambovitis, and C. A. Borrebaeck, Induction of antigenspecific isotype switching by in vitro immunization of human naive B lymphocytes, J Immunol Methods, pp.181-90, 0200.

A. Zafiropoulos, M. Kandilogiannaki, C. Dahlenborg, C. A. Borrebaeck, and E. Krambovitis, In vitro induction of somatic mutations in human peripheral B lymphocytes., International Journal of Molecular Medicine, issue.6, pp.475-84, 2000.
DOI : 10.3892/ijmm.6.4.475

J. Zhou, K. R. Lottenbach, S. J. Barenkamp, and D. C. Reason, Somatic Hypermutation and Diverse Immunoglobulin Gene Usage in the Human Antibody Response to the Capsular Polysaccharide of Streptococcus pneumoniae Type 6B, Infection and Immunity, vol.72, issue.6, pp.72-3505, 2004.
DOI : 10.1128/IAI.72.6.3505-3514.2004